Hypoxia divergently regulates production of reactive oxygen species in human pulmonary and coronary artery smooth muscle cells
Authors:
- Oleksandr PlatoshynOPOleksandr Platoshyn
- Amy L. FirthAFAmy L. Firth
- Jason X.-J. YuanJYJason X.-J. Yuan
Open Access
- 1 October 2007
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 293 (4) , L952-L959
Abstract
Acute hypoxia causes pulmonary vasoconstriction and coronary vasodilation. The divergent effects of hypoxia on pulmonary and coronary vascular smooth muscle cells suggest that the mechanisms involved in oxygen sensing and downstream effectors are different in these two types of cells. Since production of reactive oxygen species (ROS) is regulated by oxygen tension, ROS have been hypothesized to be a signaling mechanism in hypoxia-induced pulmonary vasoconstriction and vascular remodeling. Furthermore, an increased ROS production is also implicated in arteriosclerosis. In this study, we determined and compared the effects of hypoxia on ROS levels in human pulmonary arterial smooth muscle cells (PASMC) and coronary arterial smooth muscle cells (CASMC). Our results indicated that acute exposure to hypoxia (Po2 = 25–30 mmHg for 5–10 min) significantly and rapidly decreased ROS levels in both PASMC and CASMC. However, chronic exposure to hypoxia (Po2 = 30 mmHg for 48 h) markedly increased ROS levels in PASMC, but decreased ROS production in CASMC. Furthermore, chronic treatment with endothelin-1, a potent vasoconstrictor and mitogen, caused a significant increase in ROS production in both PASMC and CASMC. The inhibitory effect of acute hypoxia on ROS production in PASMC was also accelerated in cells chronically treated with endothelin-1. While the decreased ROS in PASMC and CASMC after acute exposure to hypoxia may reflect the lower level of oxygen substrate available for ROS production, the increased ROS production in PASMC during chronic hypoxia may reflect a pathophysiological response unique to the pulmonary vasculature that contributes to the development of pulmonary vascular remodeling in patients with hypoxia-associated pulmonary hypertension.Keywords
This publication has 62 references indexed in Scilit:
- Nox4 Is Required for Maintenance of the Differentiated Vascular Smooth Muscle Cell PhenotypeArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- TRPC Channel Upregulation in Chronically Hypoxic Pulmonary ArteriesCirculation Research, 2006
- Modulation of Voltage-dependent Shaker Family Potassium Channels by an Aldo-Keto Reductase*Journal of Biological Chemistry, 2006
- Ca2+‐desensitizing hypoxic vasorelaxation: pivotal role for the myosin binding subunit of myosin phosphatase (MYPT1) in porcine coronary arteryThe Journal of Physiology, 2006
- Regulation of NADPH OxidasesCirculation Research, 2006
- Does AMP-activated Protein Kinase Couple Inhibition of Mitochondrial Oxidative Phosphorylation by Hypoxia to Calcium Signaling in O2-sensing Cells?Journal of Biological Chemistry, 2005
- H 2 O 2 -Induced Proliferation of Primary Alveolar Epithelial Cells Is Mediated by MAP KinasesAntioxidants & Redox Signaling, 2005
- Structural characterization, tissue distribution, and functional expression of murine aminoacylase IIIAmerican Journal of Physiology-Cell Physiology, 2004
- Coupling of Voltage-dependent Potassium Channel Inactivation and Oxidoreductase Active Site of Kvβ SubunitsJournal of Biological Chemistry, 2001
- Mutations in the Kvβ2 Binding Site for NADPH and Their Effects on Kv1.4Journal of Biological Chemistry, 2001